Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

NCT06395844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: METR-NK cell(Metabolic Remodeling Nature Killer Cells)

Sponsor

Anhui Provincial Cancer Hospital

Collaborators

[object Object]